| (Values in U.S. Thousands) | May, 2020 | May, 2019 | May, 2018 | Feb, 2018 | Nov, 2017 |
| Sales | 405,770 | 179,280 | 29,050 | 0 | 0 |
| Sales Growth | +126.33% | +517.14% | unch | unch | unch |
| Net Income | -63,200 | -12,470 | 23,170 | 0 | 0 |
| Net Income Growth | -406.82% | -153.82% | unch | unch | unch |
Aphria Inc (APHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada.
Fiscal Year End Date: 05/31